Lugano Classification Stage IV Hodgkin Lymphoma AJCC v8 Clinical Trials in Boston, Massachusetts

Personalized Reduction of Chemotherapy Intensity Through ctDNA Evaluation for the Treatment of Patients With Advanced Hodgkin Lymphoma